Prof. Gareth Evans, Consultant Geneticist
Prof. Gareth Evans
Consultant Geneticist
Prof. Gareth Evans MB BS, FRCP, MD
Consultant Geneticist
Prof. Gareth Evans
Consultant Geneticist MB BS, FRCP, MD
Areas of expertise
- Cancer genetics
- Neurofibromatosis
- Breast cancer
- Ovarian cancer
About Prof. Gareth Evans
GMC number: 2818946
Year qualified: 1983
Place of primary qualification: University of London
Prof. Gareth Evans is a consultant geneticist based at Manchester University NHS Trust. He also sees patients privately at The Christie Private Care. Prof. Evans has gained a national and international reputation for his work in the clinical and research aspects of cancer genetics, particularly in neurofibromatosis and breast cancer.
Since his appointment, Prof. Evans has developed a highly regarded clinical service for cancer genetics in the North West of England. He is a key opinion leader on hereditary breast cancer and cancer syndromes, frequently lecturing both in the UK and abroad.
Prof. Evans has also established a national training programme for clinicians, nurses, and genetic counsellors in breast cancer genetics. He has set up a comprehensive system for risk assessment and counselling for breast cancer.
With an impressive portfolio of research, Prof. Evans has published approximately 980 peer-reviewed research publications, with 350 as first or senior author and over 220 focused on neurofibromatosis. He led a successful bid for a nationally funded NF2 service, securing £7.5 million per year, which commenced in 2010.
His areas of expertise include hereditary cancer screening, genetics, breast cancer, and neurofibromatosis. Prof. Evans is dedicated to advancing the field of cancer genetics and improving patient care through his extensive research and clinical work.
Areas of expertise
- Cancer genetics
- Neurofibromatosis
- Breast cancer
- Ovarian cancer
Professional memberships
Articles by Prof. Gareth Evans
Correction to: choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer
Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer
Uptake of hysterectomy and bilateral salpingo- oophorectomy in carriers of pathogenic mismatch repair variants: a prospective lynch syndrome database report
Surgical decision making in premenopausal brca carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study
Germline ffpe inherited cancer panel testing in deceased family members: implications for clinical management of unaffected relatives
Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women
Comment on: smarcb1 gene mutation predisposes to earlier development of glioblastoma: a case report of familial gbm
A case-only study to identify genetic modifiers of breast cancer risk for brca1/brca2 mutation carriers
Uptake and efficacy of bilateral risk reducing surgery in unaffected female brca1 and brca2 carriers